Over-The-Counter Drug Market Report

Europe Over-The-Counter Drug Market Size, Status and Forecast 2014-2026

  • POSTDATE：Oct 17, 2019
  • PAGES：170
  • REPORT CODE：GMM328417
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Over-The-Counter Drug market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 6.8% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Over-The-Counter Drug Market Segmentations:

    By Player:

    • Eisai

    • Genomma Lab Internacional

    • Chr Hansen

    • Euradite

    • Johnson & Johnson

    • GlaxoSmithKline (GSK)

    • Dr. Reddy's Laboratories

    • Glanbia

    • CoLucid

    • AstraZeneca

    • Eli Lilly

    • Sanofi

    • BioGaia

    • Pfizer

    • DSM

    • Dr Reddy's Laboratories

    • Daiichi Sankyo

    • EMS

    • Bukwang Pharmaceutica

    • Bayer HealthCare

    • Friggs

    • Cipla

    • Chr. Hansen

    By Type:

    • Type 1

    • Type 2

    • Type 3

    By End-User:

    • End-Users 1

    • End-Users 2

    • End-Users 3

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Over-The-Counter Drug Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Over-The-Counter Drug Market Size and Growth Rate of Type 1 from 2014 to 2026

    • 1.3.2 Europe Over-The-Counter Drug Market Size and Growth Rate of Type 2 from 2014 to 2026

    • 1.3.3 Europe Over-The-Counter Drug Market Size and Growth Rate of Type 3 from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Over-The-Counter Drug Market Size and Growth Rate of End-User 1 from 2014 to 2026

    • 1.4.2 Europe Over-The-Counter Drug Market Size and Growth Rate of End-User 2 from 2014 to 2026

    • 1.4.3 Europe Over-The-Counter Drug Market Size and Growth Rate of End-User 3 from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Over-The-Counter Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Over-The-Counter Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Over-The-Counter Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Over-The-Counter Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Over-The-Counter Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Over-The-Counter Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Over-The-Counter Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Over-The-Counter Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Over-The-Counter Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Over-The-Counter Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Over-The-Counter Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Over-The-Counter Drug Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Over-The-Counter Drug Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Over-The-Counter Drug by Major Types

      • 3.4.1 Market Size and Growth Rate of Type 1

      • 3.4.2 Market Size and Growth Rate of Type 2

      • 3.4.3 Market Size and Growth Rate of Type 3

    4 Segmentation of Over-The-Counter Drug Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Over-The-Counter Drug by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Over-The-Counter Drug for End-Users 1

      • 4.4.2 Market Size and Growth Rate of Over-The-Counter Drug for End-Users 2

      • 4.4.3 Market Size and Growth Rate of Over-The-Counter Drug for End-Users 3

    5 Market Analysis by Major Regions

    • 5.1 Europe Over-The-Counter Drug Production Analysis by Top Regions

    • 5.2 Europe Over-The-Counter Drug Consumption Analysis by Top Regions

    • 5.3 Europe Over-The-Counter Drug Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Over-The-Counter Drug Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Over-The-Counter Drug Production, Import, Consumption and Export Analysis

      • 5.3.3 France Over-The-Counter Drug Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Over-The-Counter Drug Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Over-The-Counter Drug Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Over-The-Counter Drug Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Over-The-Counter Drug Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Over-The-Counter Drug Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Over-The-Counter Drug Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Over-The-Counter Drug Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Over-The-Counter Drug Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Over-The-Counter Drug Production, Import, Consumption and Export Analysis

    6 Product Circulation of Over-The-Counter Drug Market among Top Countries

    • 6.1 Top 5 Export Countries in Over-The-Counter Drug Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Over-The-Counter Drug Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Over-The-Counter Drug Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Over-The-Counter Drug Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Over-The-Counter Drug Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Over-The-Counter Drug Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Over-The-Counter Drug Landscape Analysis

    • 7.1 Germany Over-The-Counter Drug Landscape Analysis by Major Types

    • 7.2 Germany Over-The-Counter Drug Landscape Analysis by Major End-Users

    8. UK Over-The-Counter Drug Landscape Analysis

    • 8.1 UK Over-The-Counter Drug Landscape Analysis by Major Types

    • 8.2 UK Over-The-Counter Drug Landscape Analysis by Major End-Users

    9. France Over-The-Counter Drug Landscape Analysis

    • 9.1 France Over-The-Counter Drug Landscape Analysis by Major Types

    • 9.2 France Over-The-Counter Drug Landscape Analysis by Major End-Users

    10. Italy Over-The-Counter Drug Landscape Analysis

    • 10.1 Italy Over-The-Counter Drug Landscape Analysis by Major Types

    • 10.2 Italy Over-The-Counter Drug Landscape Analysis by Major End-Users

    11. Spain Over-The-Counter Drug Landscape Analysis

    • 11.1 Spain Over-The-Counter Drug Landscape Analysis by Major Types

    • 11.2 Spain Over-The-Counter Drug Landscape Analysis by Major End-Users

    12. Poland Over-The-Counter Drug Landscape Analysis

    • 12.1 Poland Over-The-Counter Drug Landscape Analysis by Major Types

    • 12.2 Poland Over-The-Counter Drug Landscape Analysis by Major End-Users

    13. Russia Over-The-Counter Drug Landscape Analysis

    • 13.1 Russia Over-The-Counter Drug Landscape Analysis by Major Types

    • 13.2 Russia Over-The-Counter Drug Landscape Analysis by Major End-Users

    14. Switzerland Over-The-Counter Drug Landscape Analysis

    • 14.1 Switzerland Over-The-Counter Drug Landscape Analysis by Major Types

    • 14.2 Switzerland Over-The-Counter Drug Landscape Analysis by Major End-Users

    15. Turkey Over-The-Counter Drug Landscape Analysis

    • 15.1 Turkey Over-The-Counter Drug Landscape Analysis by Major Types

    • 15.2 Turkey Over-The-Counter Drug Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Over-The-Counter Drug Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Over-The-Counter Drug Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Over-The-Counter Drug Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Over-The-Counter Drug Landscape Analysis by Top Countries

      • 16.3.1 Denmark Over-The-Counter Drug Market Volume and Growth Rate

      • 16.3.2 Finland Over-The-Counter Drug Market Volume and Growth Rate

      • 16.3.3 Norway Over-The-Counter Drug Market Volume and Growth Rate

      • 16.3.4 Sweden Over-The-Counter Drug Market Volume and Growth Rate

      • 16.3.6 Iceland Over-The-Counter Drug Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Over-The-Counter Drug Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Over-The-Counter Drug Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Over-The-Counter Drug Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Over-The-Counter Drug Landscape Analysis by Top Countries

      • 17.3.1 Belgium Over-The-Counter Drug Market Volume and Growth Rate

      • 17.3.2 Netherlands Over-The-Counter Drug Market Volume and Growth Rate

      • 17.3.3 Luxembourg Over-The-Counter Drug Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Over-The-Counter Drug Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Over-The-Counter Drug Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Over-The-Counter Drug Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Over-The-Counter Drug Landscape Analysis by Top Countries

      • 18.3.1 Estonia Over-The-Counter Drug Market Volume and Growth Rate

      • 18.3.2 Latvia Over-The-Counter Drug Market Volume and Growth Rate

      • 18.3.3 Lithuania Over-The-Counter Drug Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 Eisai

      • 19.1.1 Eisai Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 Genomma Lab Internacional

      • 19.2.1 Genomma Lab Internacional Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 Chr Hansen

      • 19.3.1 Chr Hansen Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 Euradite

      • 19.4.1 Euradite Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 Johnson & Johnson

      • 19.5.1 Johnson & Johnson Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 GlaxoSmithKline (GSK)

      • 19.6.1 GlaxoSmithKline (GSK) Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 Dr. Reddy's Laboratories

      • 19.7.1 Dr. Reddy's Laboratories Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    • 19.8 Glanbia

      • 19.8.1 Glanbia Company Profile and Development Status

      • 19.8.2 Market Performance

      • 19.8.3 Product and Service Introduction

    • 19.9 CoLucid

      • 19.9.1 CoLucid Company Profile and Development Status

      • 19.9.2 Market Performance

      • 19.9.3 Product and Service Introduction

    • 19.10 AstraZeneca

      • 19.10.1 AstraZeneca Company Profile and Development Status

      • 19.10.2 Market Performance

      • 19.10.3 Product and Service Introduction

    • 19.11 Eli Lilly

      • 19.11.1 Eli Lilly Company Profile and Development Status

      • 19.11.2 Market Performance

      • 19.11.3 Product and Service Introduction

    • 19.12 Sanofi

      • 19.12.1 Sanofi Company Profile and Development Status

      • 19.12.2 Market Performance

      • 19.12.3 Product and Service Introduction

    • 19.13 BioGaia

      • 19.13.1 BioGaia Company Profile and Development Status

      • 19.13.2 Market Performance

      • 19.13.3 Product and Service Introduction

    • 19.14 Pfizer

      • 19.14.1 Pfizer Company Profile and Development Status

      • 19.14.2 Market Performance

      • 19.14.3 Product and Service Introduction

    • 19.15 DSM

      • 19.15.1 DSM Company Profile and Development Status

      • 19.15.2 Market Performance

      • 19.15.3 Product and Service Introduction

    • 19.16 Dr Reddy's Laboratories

      • 19.16.1 Dr Reddy's Laboratories Company Profile and Development Status

      • 19.16.2 Market Performance

      • 19.16.3 Product and Service Introduction

    • 19.17 Daiichi Sankyo

      • 19.17.1 Daiichi Sankyo Company Profile and Development Status

      • 19.17.2 Market Performance

      • 19.17.3 Product and Service Introduction

    • 19.18 EMS

      • 19.18.1 EMS Company Profile and Development Status

      • 19.18.2 Market Performance

      • 19.18.3 Product and Service Introduction

    • 19.19 Bukwang Pharmaceutica

      • 19.19.1 Bukwang Pharmaceutica Company Profile and Development Status

      • 19.19.2 Market Performance

      • 19.19.3 Product and Service Introduction

    • 19.20 Bayer HealthCare

      • 19.20.1 Bayer HealthCare Company Profile and Development Status

      • 19.20.2 Market Performance

      • 19.20.3 Product and Service Introduction

    • 19.21 Friggs

      • 19.21.1 Friggs Company Profile and Development Status

      • 19.21.2 Market Performance

      • 19.21.3 Product and Service Introduction

    • 19.22 Cipla

      • 19.22.1 Cipla Company Profile and Development Status

      • 19.22.2 Market Performance

      • 19.22.3 Product and Service Introduction

    • 19.23 Chr. Hansen

      • 19.23.1 Chr. Hansen Company Profile and Development Status

      • 19.23.2 Market Performance

      • 19.23.3 Product and Service Introduction

    The List of Tables and Figures (Totals 107 Figures and 149 Tables)

    • Figure Product Picture

    • Figure Europe Over-The-Counter Drug Market Size and Growth Rate of Type 1 from 2014 to 2026

    • Figure Europe Over-The-Counter Drug Market Size and Growth Rate of Type 2 from 2014 to 2026

    • Figure Europe Over-The-Counter Drug Market Size and Growth Rate of Type 3 from 2014 to 2026

    • Figure Europe Over-The-Counter Drug Market Size and Growth Rate of End-User 1 from 2014 to 2026

    • Figure Europe Over-The-Counter Drug Market Size and Growth Rate of End-User 2 from 2014 to 2026

    • Figure Europe Over-The-Counter Drug Market Size and Growth Rate of End-User 3 from 2014 to 2026

    • Figure Germany Over-The-Counter Drug Market Size and Growth Rate from 2014 to 2026

    • Figure UK Over-The-Counter Drug Market Size and Growth Rate from 2014 to 2026

    • Figure France Over-The-Counter Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Over-The-Counter Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Over-The-Counter Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Over-The-Counter Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Over-The-Counter Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Over-The-Counter Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Over-The-Counter Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Over-The-Counter Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Over-The-Counter Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Over-The-Counter Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Over-The-Counter Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Over-The-Counter Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Over-The-Counter Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Over-The-Counter Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Over-The-Counter Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Over-The-Counter Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Over-The-Counter Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Over-The-Counter Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Over-The-Counter Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Over-The-Counter Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Over-The-Counter Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Over-The-Counter Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Over-The-Counter Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Over-The-Counter Drug Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Over-The-Counter Drug

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Over-The-Counter Drug by Different Types from 2014 to 2026

    • Table Consumption Share of Over-The-Counter Drug by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Type 1

    • Figure Market Size and Growth Rate of Type 2

    • Figure Market Size and Growth Rate of Type 3

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Over-The-Counter Drug by Different End-Users from 2014 to 2026

    • Table Consumption Share of Over-The-Counter Drug by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of End-User 1

    • Figure Market Size and Growth Rate of End-User 2

    • Figure Market Size and Growth Rate of End-User 3

    • Table Europe Over-The-Counter Drug Production by Major Regions

    • Table Europe Over-The-Counter Drug Production Share by Major Regions

    • Figure Europe Over-The-Counter Drug Production Share by Major Countries and Regions in 2014

    • Table Europe Over-The-Counter Drug Consumption by Major Regions

    • Table Europe Over-The-Counter Drug Consumption Share by Major Regions

    • Table Germany Over-The-Counter Drug Production, Import, Consumption and Export Analysis

    • Table UK Over-The-Counter Drug Production, Import, Consumption and Export Analysis

    • Table France Over-The-Counter Drug Production, Import, Consumption and Export Analysis

    • Table Italy Over-The-Counter Drug Production, Import, Consumption and Export Analysis

    • Table Spain Over-The-Counter Drug Production, Import, Consumption and Export Analysis

    • Table Poland Over-The-Counter Drug Production, Import, Consumption and Export Analysis

    • Table Russia Over-The-Counter Drug Production, Import, Consumption and Export Analysis

    • Table Switzerland Over-The-Counter Drug Production, Import, Consumption and Export Analysis

    • Table Turkey Over-The-Counter Drug Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Over-The-Counter Drug Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Over-The-Counter Drug Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Over-The-Counter Drug Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Over-The-Counter Drug Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Over-The-Counter Drug Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Over-The-Counter Drug Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Over-The-Counter Drug Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Over-The-Counter Drug Consumption by Types from 2014 to 2026

    • Table Germany Over-The-Counter Drug Consumption Share by Types from 2014 to 2026

    • Table Germany Over-The-Counter Drug Consumption by End-Users from 2014 to 2026

    • Table Germany Over-The-Counter Drug Consumption Share by End-Users from 2014 to 2026

    • Table UK Over-The-Counter Drug Consumption by Types from 2014 to 2026

    • Table UK Over-The-Counter Drug Consumption Share by Types from 2014 to 2026

    • Table UK Over-The-Counter Drug Consumption by End-Users from 2014 to 2026

    • Table UK Over-The-Counter Drug Consumption Share by End-Users from 2014 to 2026

    • Table France Over-The-Counter Drug Consumption by Types from 2014 to 2026

    • Table France Over-The-Counter Drug Consumption Share by Types from 2014 to 2026

    • Table France Over-The-Counter Drug Consumption by End-Users from 2014 to 2026

    • Table France Over-The-Counter Drug Consumption Share by End-Users from 2014 to 2026

    • Table Italy Over-The-Counter Drug Consumption by Types from 2014 to 2026

    • Table Italy Over-The-Counter Drug Consumption Share by Types from 2014 to 2026

    • Table Italy Over-The-Counter Drug Consumption by End-Users from 2014 to 2026

    • Table Italy Over-The-Counter Drug Consumption Share by End-Users from 2014 to 2026

    • Table Spain Over-The-Counter Drug Consumption by Types from 2014 to 2026

    • Table Spain Over-The-Counter Drug Consumption Share by Types from 2014 to 2026

    • Table Spain Over-The-Counter Drug Consumption by End-Users from 2014 to 2026

    • Table Spain Over-The-Counter Drug Consumption Share by End-Users from 2014 to 2026

    • Table Poland Over-The-Counter Drug Consumption by Types from 2014 to 2026

    • Table Poland Over-The-Counter Drug Consumption Share by Types from 2014 to 2026

    • Table Poland Over-The-Counter Drug Consumption by End-Users from 2014 to 2026

    • Table Poland Over-The-Counter Drug Consumption Share by End-Users from 2014 to 2026

    • Table Russia Over-The-Counter Drug Consumption by Types from 2014 to 2026

    • Table Russia Over-The-Counter Drug Consumption Share by Types from 2014 to 2026

    • Table Russia Over-The-Counter Drug Consumption by End-Users from 2014 to 2026

    • Table Russia Over-The-Counter Drug Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Over-The-Counter Drug Consumption by Types from 2014 to 2026

    • Table Switzerland Over-The-Counter Drug Consumption Share by Types from 2014 to 2026

    • Table Switzerland Over-The-Counter Drug Consumption by End-Users from 2014 to 2026

    • Table Switzerland Over-The-Counter Drug Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Over-The-Counter Drug Consumption by Types from 2014 to 2026

    • Table Turkey Over-The-Counter Drug Consumption Share by Types from 2014 to 2026

    • Table Turkey Over-The-Counter Drug Consumption by End-Users from 2014 to 2026

    • Table Turkey Over-The-Counter Drug Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Over-The-Counter Drug Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Over-The-Counter Drug Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Over-The-Counter Drug Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Over-The-Counter Drug Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Over-The-Counter Drug Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Over-The-Counter Drug Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Over-The-Counter Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Over-The-Counter Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Over-The-Counter Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Over-The-Counter Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Over-The-Counter Drug Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Over-The-Counter Drug Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Over-The-Counter Drug Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Over-The-Counter Drug Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Over-The-Counter Drug Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Over-The-Counter Drug Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Over-The-Counter Drug Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Over-The-Counter Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Over-The-Counter Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Over-The-Counter Drug Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Over-The-Counter Drug Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Over-The-Counter Drug Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Over-The-Counter Drug Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Over-The-Counter Drug Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Over-The-Counter Drug Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Over-The-Counter Drug Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Over-The-Counter Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Over-The-Counter Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Over-The-Counter Drug Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Eisai

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eisai

    • Figure Sales and Growth Rate Analysis of Eisai

    • Figure Revenue and Market Share Analysis of Eisai

    • Table Product and Service Introduction of Eisai

    • Table Company Profile and Development Status of Genomma Lab Internacional

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Genomma Lab Internacional

    • Figure Sales and Growth Rate Analysis of Genomma Lab Internacional

    • Figure Revenue and Market Share Analysis of Genomma Lab Internacional

    • Table Product and Service Introduction of Genomma Lab Internacional

    • Table Company Profile and Development Status of Chr Hansen

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Chr Hansen

    • Figure Sales and Growth Rate Analysis of Chr Hansen

    • Figure Revenue and Market Share Analysis of Chr Hansen

    • Table Product and Service Introduction of Chr Hansen

    • Table Company Profile and Development Status of Euradite

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Euradite

    • Figure Sales and Growth Rate Analysis of Euradite

    • Figure Revenue and Market Share Analysis of Euradite

    • Table Product and Service Introduction of Euradite

    • Table Company Profile and Development Status of Johnson & Johnson

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson & Johnson

    • Figure Sales and Growth Rate Analysis of Johnson & Johnson

    • Figure Revenue and Market Share Analysis of Johnson & Johnson

    • Table Product and Service Introduction of Johnson & Johnson

    • Table Company Profile and Development Status of GlaxoSmithKline (GSK)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline (GSK)

    • Figure Sales and Growth Rate Analysis of GlaxoSmithKline (GSK)

    • Figure Revenue and Market Share Analysis of GlaxoSmithKline (GSK)

    • Table Product and Service Introduction of GlaxoSmithKline (GSK)

    • Table Company Profile and Development Status of Dr. Reddy's Laboratories

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Dr. Reddy's Laboratories

    • Figure Sales and Growth Rate Analysis of Dr. Reddy's Laboratories

    • Figure Revenue and Market Share Analysis of Dr. Reddy's Laboratories

    • Table Product and Service Introduction of Dr. Reddy's Laboratories

    • Table Company Profile and Development Status of Glanbia

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Glanbia

    • Figure Sales and Growth Rate Analysis of Glanbia

    • Figure Revenue and Market Share Analysis of Glanbia

    • Table Product and Service Introduction of Glanbia

    • Table Company Profile and Development Status of CoLucid

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of CoLucid

    • Figure Sales and Growth Rate Analysis of CoLucid

    • Figure Revenue and Market Share Analysis of CoLucid

    • Table Product and Service Introduction of CoLucid

    • Table Company Profile and Development Status of AstraZeneca

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca

    • Figure Sales and Growth Rate Analysis of AstraZeneca

    • Figure Revenue and Market Share Analysis of AstraZeneca

    • Table Product and Service Introduction of AstraZeneca

    • Table Company Profile and Development Status of Eli Lilly

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lilly

    • Figure Sales and Growth Rate Analysis of Eli Lilly

    • Figure Revenue and Market Share Analysis of Eli Lilly

    • Table Product and Service Introduction of Eli Lilly

    • Table Company Profile and Development Status of Sanofi

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi

    • Figure Sales and Growth Rate Analysis of Sanofi

    • Figure Revenue and Market Share Analysis of Sanofi

    • Table Product and Service Introduction of Sanofi

    • Table Company Profile and Development Status of BioGaia

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of BioGaia

    • Figure Sales and Growth Rate Analysis of BioGaia

    • Figure Revenue and Market Share Analysis of BioGaia

    • Table Product and Service Introduction of BioGaia

    • Table Company Profile and Development Status of Pfizer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer

    • Figure Sales and Growth Rate Analysis of Pfizer

    • Figure Revenue and Market Share Analysis of Pfizer

    • Table Product and Service Introduction of Pfizer

    • Table Company Profile and Development Status of DSM

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of DSM

    • Figure Sales and Growth Rate Analysis of DSM

    • Figure Revenue and Market Share Analysis of DSM

    • Table Product and Service Introduction of DSM

    • Table Company Profile and Development Status of Dr Reddy's Laboratories

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Dr Reddy's Laboratories

    • Figure Sales and Growth Rate Analysis of Dr Reddy's Laboratories

    • Figure Revenue and Market Share Analysis of Dr Reddy's Laboratories

    • Table Product and Service Introduction of Dr Reddy's Laboratories

    • Table Company Profile and Development Status of Daiichi Sankyo

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Daiichi Sankyo

    • Figure Sales and Growth Rate Analysis of Daiichi Sankyo

    • Figure Revenue and Market Share Analysis of Daiichi Sankyo

    • Table Product and Service Introduction of Daiichi Sankyo

    • Table Company Profile and Development Status of EMS

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of EMS

    • Figure Sales and Growth Rate Analysis of EMS

    • Figure Revenue and Market Share Analysis of EMS

    • Table Product and Service Introduction of EMS

    • Table Company Profile and Development Status of Bukwang Pharmaceutica

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bukwang Pharmaceutica

    • Figure Sales and Growth Rate Analysis of Bukwang Pharmaceutica

    • Figure Revenue and Market Share Analysis of Bukwang Pharmaceutica

    • Table Product and Service Introduction of Bukwang Pharmaceutica

    • Table Company Profile and Development Status of Bayer HealthCare

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer HealthCare

    • Figure Sales and Growth Rate Analysis of Bayer HealthCare

    • Figure Revenue and Market Share Analysis of Bayer HealthCare

    • Table Product and Service Introduction of Bayer HealthCare

    • Table Company Profile and Development Status of Friggs

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Friggs

    • Figure Sales and Growth Rate Analysis of Friggs

    • Figure Revenue and Market Share Analysis of Friggs

    • Table Product and Service Introduction of Friggs

    • Table Company Profile and Development Status of Cipla

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cipla

    • Figure Sales and Growth Rate Analysis of Cipla

    • Figure Revenue and Market Share Analysis of Cipla

    • Table Product and Service Introduction of Cipla

    • Table Company Profile and Development Status of Chr. Hansen

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Chr. Hansen

    • Figure Sales and Growth Rate Analysis of Chr. Hansen

    • Figure Revenue and Market Share Analysis of Chr. Hansen

    • Table Product and Service Introduction of Chr. Hansen

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US